CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $36,746,806 | -35.4% | 6,657,030 | 0.0% | 0.82% | -32.3% |
Q2 2023 | $56,851,036 | -19.7% | 6,657,030 | -13.6% | 1.21% | -3.5% |
Q1 2023 | $70,795,294 | -20.2% | 7,703,514 | -11.3% | 1.26% | -33.0% |
Q4 2022 | $88,669,051 | -31.2% | 8,684,530 | -0.8% | 1.87% | -44.8% |
Q3 2022 | $128,903,000 | +37.2% | 8,757,030 | 0.0% | 3.39% | +68.3% |
Q2 2022 | $93,963,000 | -0.5% | 8,757,030 | 0.0% | 2.01% | +2.2% |
Q1 2022 | $94,401,000 | -33.9% | 8,757,030 | 0.0% | 1.97% | -10.7% |
Q4 2021 | $142,915,000 | -23.8% | 8,757,030 | 0.0% | 2.21% | -10.0% |
Q3 2021 | $187,488,000 | – | 8,757,030 | – | 2.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Blue Water Life Science Advisors, LP | 1,300,000 | $13,273,000 | 8.92% |
Miura Global Management | 780,000 | $7,963,800 | 4.01% |
RA Capital Management | 13,381,054 | $136,620,561 | 2.77% |
HHLR ADVISORS, LTD. | 8,684,530 | $88,669,051 | 1.87% |
Brown Capital Management | 5,107,878 | $52,151,434 | 0.86% |
Perceptive Advisors | 1,289,534 | $13,166,142 | 0.37% |
Hillsdale Investment Management Inc. | 344,529 | $3,517,641 | 0.30% |
PURA VIDA INVESTMENTS, LLC | 420,749 | $4,295,847 | 0.22% |
FOX RUN MANAGEMENT, L.L.C. | 19,881 | $202,985 | 0.08% |
INNOVIS ASSET MANAGEMENT LLC | 14,565 | $148,709 | 0.07% |